The Leukemia & Lymphoma Society, Inc.

The Leukemia & Lymphoma Society, Inc.

The Leukemia & Lymphoma Society, Inc.

Overview
Date Founded

1949

Charitable Causes

Cancer Research

Employees (Worldwide)

1,291

Industries

Other Business & Consulting Services
Market & Policy Research

Company Description

The Leukemia & Lymphoma Society (LLS) is the world’s largest voluntary health organization dedicated to funding blood cancer research and providing education and patient services.  Founded in 1949, it is relentless in pursuit of its mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.

Contact Data
Trying to get in touch with decision makers at The Leukemia & Lymphoma Society, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

President & Chief Executive Officer

Chief Administrative Officer & Chief Financial Officer

Executive Vice President & Chief Operating Officer

Executive Vice President, General Counsel

Executive Vice President, Chief Marketing Officer

Chief Development Officer

Executive Vice President, Chief Communications Officer

Chief of Staff

Executive Vice President, Products & Campaign Development

Benefit Plan Administrator

Board of Directors

Former Chief Executive Officer of United States & Managing Director, North America at Accenture LLP

Chief Marketing Officer & Executive Vice President at Burlington Coat Factory Investments Holdings, Inc.

Chair, Department of Hematology at Mayo Clinic

Head of Corporate Social Responsibility & Global Diversity & Inclusion at Northern Trust Corporation

Founder at Boston Millennia Partners

Former Managing Director at Pacific Investment Management Co. LLC

Founder at Bk97 Digital

Policy Analyst, White House Cancer Moonshot Office at Office of the Vice President Under Barack Obama

President & Chief Executive Officer at Alice Hyde Medical Center

Chief Executive Officer & President at WOMN LLC

Paths to The Leukemia & Lymphoma Society, Inc.
Potential Connections via
Relationship Science
You
The Leukemia & Lymphoma Society, Inc.
Advisors & Consultants
Advisor

Chair, Department of Hematology at Mayo Clinic

Advisor

Director, Division of Hematology, Department of Internal Medicine at The Ohio State University Wexner Medical Center

Advisor

Assistant Professor, Department of Population Sciences at City of Hope - California

Clients

Curis, Inc. engages in the development and commercialization of drug candidates for the treatment of human cancers. Its pipeline includes CUDC-907, CA-4948, CA-170, and CA-327. The CUDC-907 pipeline is an orally available small molecule inhibitor of HDAC and PI3K enzymes. The CA-170 pipeline is an also an orally-available small molecule antagonist of PD-L1 and VISTA immune checkpoints. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Key Stats and Financials As of 2018
Market Capitalization
Total Enterprise Value
Earnings Per Share
Revenue
$439M
Non-Profit Donations & Grants
Non-Profit Donations & Grants Received
Political Donations
$50
2005
Investments
Details Hidden

Kymera Therapeutics LLC operates as a biotechnology company for curing untreatable diseases. The firm's proprietary integrated degradation platform consists of informatics-driven target identification, novel E3 ligases and ligands, proprietary predictive modeling, and novel degradation tools. The company was founded by Nello Mainolfi and Laurent Audoly and is headquartered in Cambridge, MA.

Details Hidden

TetraLogic Research & Development Corp. develops SHP-141 topical HDAC inhibitor clinical development for cutaneous T cell lymphoma. Its currently conducting a randomized, double-blind, placebo controlled, phase 1b study, to evaluate the safety and tolerability of SHP-141 in patients with stage 1A, 1B or 2A CTCL. The company was founded by James E. Bradner and Ralph Mazitschek in 2008 and is headquartered in Cambridge, MA.

Details Hidden

OncoPep, Inc. develops immunotherapeutics to prevent the progression of cancer, prolong survival, and restore the quality of life of patients. The company's product, PVX-410, is a multi-peptide therapeutic cancer vaccine to target specific antigens found on the surface of multiple myeloma cancer cells. Its PVX-410 is targeted for smoldering multiple myeloma, a precursor disease. The company was founded by Doris Peterkin, Joslyn Dobson, and Marc A. Cohen in 2010 and is headquartered in North Andover, MA.

Suppliers
Affimed NV Medical Support Services | Heidelberg, Deu

Affimed NV engages in discovering and developing of targeted cancer immunotherapies. Its pipelines include Innate Cell Engagers and T Cell Engagers. The company was founded in 2000 and is headquartered in Heidelberg, Germany.

Kite Pharma, Inc. Medical Support Services | Santa Monica, CA

Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam in June 2009 and is headquartered in Santa Monica, CA.

InfoCision, Inc. Other Business & Consulting Services | Akron, OH

InfoCision, Inc. provides inbound and outbound teleservices. The firm offers call center, interactive online solutions, data analytics, mail and variable print. The company was founded by Gary L. Taylor and Karen Taylor in 1982 and is headquartered in Akron, OH.

Awards & Honors
Rank #55
2014
NonProfit Times - Top 100
Sponsored by The NonProfit Times
Rank #52
2013
NonProfit Times - Top 100
Sponsored by The NonProfit Times
Rank #51
2012
NonProfit Times - Top 100
Sponsored by The NonProfit Times
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by The Leukemia & Lymphoma Society, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of The Leukemia & Lymphoma Society, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and The Leukemia & Lymphoma Society, Inc..